Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer
Clinical trial NCT07621562 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07621562
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2027-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.